REFERENCES
- Meinertz T, Hamm CW. Rapid testing for cardiac troponins in patients with acute chest pain in the emergency room. Eur Heart J 1998; 19: 973–4.
- Roth A, Malov N, Bloch Y, Golovner M, Slesarenko Y, Naveh R, Kaplinsky E, Laniado S. Assessment of a creatinine kinase-MB/myo-globin kit in the prehospital setting in patients presenting with acute nontraumatic chest pain: the "shahal" experience. Crit Care Med 1999; 27: 1085— 9.
- Pettersson K, Katajamäki T, hjala K, Leppänen V, Majamaa-Voltti K, Laitinen P. Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma. Luminescence 2000; 15: 1–9.
- Lövgren T, Meriö L, Mitrunen K, Mäkinen ML, Makeld M, Blomberg K, Palenius T, Pettersson K. One-step all-in-one dry reagent immunoassays using a fluorescent Europium chelate label and time-resolved fluorometry. Clin Chem 1996; 42: 1196–201.
- Hedberg P, Valkama J, Puukka M. Evaluation of a rapid Innotrac Aiol immunoanalyzer for quan-tification of cardiac markers. Clin Chem Lab Med 2001; 39 Suppl. P0–S007: 331.
- Panteghini M, Pagani F. Biological variation of myoglobin in serum. Clin Chem 1997; 43: 2435.
- Hedberg P, Melkko T, Valkama J, Puukka M. Higher CK-MB mass value in heparin plasma than in serum measured with the Abbott AxSYM system. Clin Chem Lab Med 2001; 39: 872–4.
- Price A, Burgin C, Cruise M. Stability of cardiac troponin and CK-MB mass isoenzyme. Clin Chem Lab Med 2000; 38: 1159–60.
- Katrukha A, Bereznikova A, Filatov V, Esakova T, Kolosova 0, Pettersson K, Lovgren T, Bulargina T, Trifonov I, Gratsiansky N, Pulkki K, Voipio-Pulkki LM, Gusev N. Degradation of cardiac troponin I: implication for reliable immuno-detection. Clin Chem 1998; 44: 2433–40.
- Wu A, Apple F, Gibler W, Jesse R, Warshaw M, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104–21.
- Panteghini M, Apple F, Christenson R, Dati F, Mair J, Wu A. Use of biochemical markers in acute coronary syndromes: IFCC Scientific Divi-sion, Committee on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med 1999; 37: 687–93.
- The Joint European Society of Cardiology/Amer-ican College of Cardiology Committee. Myocar-dial infarction redefined—A consensus document of the Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–69.
- Braunwald E, Antman E, Beasley J, Calif R, Cheitlin M, Hochman J, Jones R, Kereiakes D, Kupersmith J. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Manage-ment of Patients with Unstable Angina). Circula-tion 2000; 102: 1193–209.
- Ross SM, Fraser CG. Biological variation of cardiac markers: analytical and clinical considera-tions. Ann Clin Biochem 1998; 35: 80–4.
- Dasgupta A, Banerjee SK, Datta PFalsehyphen-positivetroponin. I in the MEIA due to the presence of rheumatoid factors in serum. Elimina-tion of this interference by using a polyclonal antisera against rheumatoid factors. Am J Clin Pathol 1999; 112: 753–6.
- Zaman Z, De Spiegeleer S, Gerits M, Blanckaert N. Analytical and clinical performance of two cardiac troponin I immunoassays. Clin Chem Lab Med 1999; 37: 889–97.
- Quinn-Hall K, Bateman S, Wu A, Wieczorek S, Ficher G, Yeo K. Functional sensitivity of cardiac troponin assays and implications for risk stratifi-cation (Abstract). Clin Chem 2000; 46: A78.
- Hamm C, Goldmann B, Heeshen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648–53.